Cooper Health System IRB – FDA 483, Dec 4, 2025

The FDA inspected Cooper Health System IRB in Camden, NJ, and issued a Form 483 with four observations. The observations primarily concern the lack of adequate written procedures for various critical IRB functions, including project review frequency, reporting findings, initial research review, and reporting noncompliance. This indicates significant procedural deficiencies in the IRB's operations.